Laboratory automation for small molecule high-throughput screening and cell-based assays
Dr. Marie Hazel Foss, a Cellular Metabolism scientist at Cayman Chemical, will present her work on how the Agilent laboratory automation solutions streamlines HTS in the drug discovery process. The presentation shows how the Agilent Bravo Automated Liquid Handling Platform enhances productivity and efficiency of small molecule high-throughput screening and cell-based metabolism assays.
Key learning objectives
- Understand the benefits of laboratory automation for liquid handling tasks
Explore basic methods for small molecule high-throughput screening
Explore basic methods for cellular metabolism assay optimization
Who should attend?
- Laboratory managers and technicians
- Life science undergraduate and graduate students
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
Speakers
Dr. Marie Hazel Foss currently supports the Cellular Metabolism and HTS contract services group at Cayman Chemical. Prior to this, she led drug development at Neuralexo, Inc. for five years towards filing of a patent for stroke therapeutics. Previous drug development work at the University of Wisconsin Madison resulted in a patent for bacterial membrane-targeted antibiotics. Dr. Foss has supported small molecule screening for enzyme-based and cell-based methods, including kinases, GPCRs, and gyrase targets.
Moderator
